SCHEMBL27366938

SCHEMBL27366938

OCCc1cccc2ccc(Cl)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 12/20 0.41
MTNR1B P49286 8/20 0.41
CYP2A6 P11509 1/20 0.41
HTR2A P28223 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
ALPG P10696 1/20 0.38
CYP2C9 P11712 1/20 0.38
HTT P42858 1/20 0.38
NQO2 P16083 3/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3571906 0.85 CYP2A6 (0.43) CYP2A6MEN1KMT2ACYP1A2CYP2C19
SCHEMBL29792638 0.85 CYP2A6 (0.43) CYP2A6MEN1KMT2ACYP1A2CYP2C19
SCHEMBL27366935 0.82 CYP2A6 (0.41) MTNR1AMTNR1BCYP2A6HTR2AMEN1
SCHEMBL2312427 0.81 MTNR1A (0.40) MTNR1AMTNR1BHTR2ANQO2HTR2C
SCHEMBL11584656 0.79 CYP2A6 (0.45) CYP2A6HTR2AMEN1KMT2ACYP1A2
SCHEMBL29792747 0.79 CYP2A6 (0.45) CYP2A6HTR2AMEN1KMT2ACYP1A2
SCHEMBL9711171 0.79 MEN1 (0.45) CYP2A6MEN1KMT2ACYP1A2CYP2C19
SCHEMBL2312110 0.79 MTNR1A (0.39) MTNR1AMTNR1BHTR2ANQO2HTR2C
SCHEMBL2310265 0.79 ALDH1A1 (0.57) MTNR1AMTNR1BCYP2A6HTR2ACYP1A2
SCHEMBL27366111 0.78 HTR2A (0.64) MTNR1AMTNR1BHTR2AMAPTHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333371-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-10-30 US disclosed
EP-4532462-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-04-09 EP disclosed
CN-119384406-A Compounds of formula (I) 赛洛私人有限公司 2025-01-28 CN disclosed
WO-2023230649-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-12-07 WO disclosed
WO-2023230649-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333371-A1 COMPOUNDS SDHA, PYGB, SLC18A2 MTNR1A 1247/4885MTNR1B 757/4885CYP2A6 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.